Price $67.33 |
Market Cap
76.9B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
64.4
|
P/B
4.07
|
P/S
5.59
|
Dividend %
-
|
|
P/CF
120.9
|
P/FCF
45.1
|
Op. Cash Flow
2.35M
|
FCF
1.1
|
|
Op. Margin
15.70%
|
Net Margin
8.70%
|
ROE
6.60%
|
ROI
3.80%
|
|
ROA
3.60%
|
EPS Growth
96.70%
|
Current Ratio
1.5
|
Debt/Equity
50.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $15.43 | - | - | 197.4M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.04 | - | - | 5M | Strong Buy |
| Myomo Inc (MYO) | $3.19 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.10 | - | - | 8.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
